The US Food and Drug Administration approved the revised label for inclisiran, a small interfering RNA that reduces the ...

The document was designed to promote standardization and identify future research goals in this rapidly-growing field.

Boston Scientific is recommending updates to the instructions for use to minimize the issue, which has been tied to 17 deaths ...

When considering lead replacement, physicians should weigh the risks and benefits of extraction versus abandonment.

A new meta-analysis lends support to the idea, but researchers caution many specifics must still be worked out.

The law is set to impact hospitals, practices, clinicians, and patients in an already-strained healthcare landscape.

In anthropometric testing, the head of the bed and nursing positions received less scatter with the EggNest versus Rampart.

Concept Medical Inc., a global pioneer in drug-delivery technologies, today announced the enrollment of the first patient in ...

In patients with type 2 diabetes and CVD, the GIP/GLP-1 agonist was as good as the older drug, and possibly better in some ...

Clinical trials face challenges with variability in echo images, protocol adherence, and data quality. This discussion ...

Some good news, some ‘sobering,’ this month for tricuspid valve interventions, physician payments, and colchicine.

A joint SCCT/SCAI panel reviewed many opportunities for CT to enhance procedural planning and foster multidisciplinary care.